The present invention relates to a method for the treatment of patients suffering from certain neoplastic disease states which comprises administering a therapeutically effective amount of a compound of the formula
wherein m is an integer 6 to 9, Z is a saturated (C₂-C₆) alkylene moiety, each R group independently is hydrogen, methyl, ethyl, or n-propyl except that both R groups cannot be hydrogen when Z is a straight chain; or a pharmaceutically acceptable acid addition salt thereof. Said treatment can optionally comprise conjunctive therapy with a polyamine oxidase inhibitor. The invention also relates to certain novel polyamine derivatives.
本发明涉及一种治疗患有某些肿瘤性疾病的患者的方法,该方法包括施用治疗有效量的 式中化合物
其中 m 为 6 至 9 的整数,Z 为饱和(C₂-C₆)亚烷基,每个 R 基独立地为氢、甲基、乙基或正丙基,但当 Z 为直链时,两个 R 基不能均为氢;或其药学上可接受的酸加成盐。所述治疗可选择包括多胺氧化酶抑制剂的联合治疗。本发明还涉及某些新型多胺衍生物。
Cloned mammalian polyamine oxidase
申请人:——
公开号:US20040229241A1
公开(公告)日:2004-11-18
Polynucleotides and the corresponding polypeptides of cloned mammalian polyamine oxidase (PAO) (including various isoforms and truncated forms) are provided. Also provided are antibodies to cloned mammalian PAO, and vectors and host cells containing cloned PAO, and methods for their use.
提供了克隆哺乳动物多胺氧化酶(PAO)(包括各种异构体和截断形式)的多核苷酸和相应的多肽。还提供了克隆哺乳动物 PAO 的抗体、含有克隆 PAO 的载体和宿主细胞及其使用方法。